A Phase II Clinical Trial of Carbon-Ion Therapy for Hepatocellular Carcinoma
Phase 2
Completed
- Conditions
- Hepatocellular Carcinoma
- Registration Number
- JPRN-UMIN000021558
- Lead Sponsor
- Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
- Brief Summary
This study confirmed safety and efficacy comparable to those reported from prior facilities.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
Not provided
Exclusion Criteria
1) Active double cancer 2) Past history of radiotherapy for the target lesion 3) Patient with gastroesophageal varix should be treated 4) 38 degrees celsius or higher of fever, except for tumor fever, or infection which requires systemic therapy 5) Pregnant women, women who may become pregnant, women who deliver with 28 days or lactating women 6) Patient who is difficult to participate this study due to psychiatric condition, uncontrolled heart disease or severe pulmonary disease 7) Patient who is not suitable to participate this study in accordance with physician's examination
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ocal control rate at 3 years
- Secondary Outcome Measures
Name Time Method 1) Disease-specific survival 2) Overall survival 3) Adverse event rate 4) Event rate for radiation induced liver disease (RILD)